Lerut Jan Paul

R3-AFP score is a new composite tool to refine prediction of hepatocellular carcinoma recurrence after liver transplantation

H. Van Vlierberghe, K. Boudjema, P. Bachellier, 2022, JHEP reports : innovation in hepatology.

International study on the outcome of locoregional therapy for liver transplant in hepatocellular carcinoma beyond Milan criteria

H. Van Vlierberghe, K. Boudjema, P. Bachellier, 2021, JHEP reports : innovation in hepatology.

Impact of locoregional therapy on post-transplant outcomes in patients with hepatocellular carcinoma beyond Milan criteria

H. Van Vlierberghe, K. Boudjema, P. Bachellier, 2021, JHEP Reports.

Extended criteria for liver transplantation in hepatocellular carcinoma. A retrospective, multicentric validation study in Belgium.

M. Peter, L. Valerio, Moreno Christophe, 2020, Surgical oncology.

AFP score and metroticket 2.0 perform similarly and could be used in a “within-ALL” clinical decision tool

H. Van Vlierberghe, K. Boudjema, P. Bachellier, 2022, JHEP reports : innovation in hepatology.